Literature DB >> 30429344

Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells.

Sai Priya Anand1,2, Jérémie Prévost1,3, Sophie Baril1,3, Jonathan Richard1,3, Halima Medjahed1, Jean-Philippe Chapleau1,3, William D Tolbert4, Sharon Kirk5, Amos B Smith5, Bruce D Wines6,7,8, Stephen J Kent9, P Mark Hogarth6,7,8, Matthew S Parsons9, Marzena Pazgier4, Andrés Finzi10,2,3.   

Abstract

HIV-1 conceals epitopes of its envelope glycoproteins (Env) recognized by antibody (Ab)-dependent cellular cytotoxicity (ADCC)-mediating antibodies. These Abs, including anti-coreceptor binding site (CoRBS) and anti-cluster A antibodies, preferentially recognize Env in its "open" conformation. The binding of anti-CoRBS Abs has been shown to induce conformational changes that further open Env, allowing interaction of anti-cluster A antibodies. We explored the possibility that CoRBS Abs synergize with anti-cluster A Abs to engage Fc-gamma receptors to mediate ADCC. We found that binding of anti-CoRBS and anti-cluster A Abs to the same gp120 is required for interaction with soluble dimeric FcγRIIIa in enzyme-linked immunosorbent assays (ELISAs). We also found that Fc regions of both Abs are required to optimally engage FcγRIIIa and mediate robust ADCC. Taken together, our results indicate that these two families of Abs act together in a sequential and synergistic fashion to promote FcγRIIIa engagement and ADCC.IMPORTANCE The "open" CD4-bound conformation of HIV-1 envelope glycoproteins is the primary target of antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies present in HIV-positive (HIV+) sera, such as anti-coreceptor binding site and anti-cluster A antibodies. Here we report that the binding of these two families of antibodies is required to engage FcγRIIIa and mediate ADCC.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  ADCC; CD4-mimetics; Env; FcγRIIIa; HIV-1; anti-cluster A antibodies; anti-coreceptor binding site antibodies; nonneutralizing antibodies

Mesh:

Substances:

Year:  2019        PMID: 30429344      PMCID: PMC6340017          DOI: 10.1128/JVI.01823-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.

Authors:  P Sondermann; R Huber; V Oosthuizen; U Jacob
Journal:  Nature       Date:  2000-07-20       Impact factor: 49.962

2.  Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a.

Authors:  E Arduin; S Arora; P R Bamert; T Kuiper; S Popp; S Geisse; R Grau; T Calzascia; G Zenke; J Kovarik
Journal:  Mol Immunol       Date:  2014-10-18       Impact factor: 4.407

3.  Crystallographic structure of an intact IgG1 monoclonal antibody.

Authors:  L J Harris; E Skaletsky; A McPherson
Journal:  J Mol Biol       Date:  1998-02-06       Impact factor: 5.469

4.  Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.

Authors:  Maxime Veillette; Anik Désormeaux; Halima Medjahed; Nour-Elhouda Gharsallah; Mathieu Coutu; Joshua Baalwa; Yongjun Guan; George Lewis; Guido Ferrari; Beatrice H Hahn; Barton F Haynes; James E Robinson; Daniel E Kaufmann; Mattia Bonsignori; Joseph Sodroski; Andrés Finzi
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a.

Authors:  Thomas H R Carlsen; Jannie Pedersen; Jannick C Prentoe; Erick Giang; Zhen-Yong Keck; Lotte S Mikkelsen; Mansun Law; Steven K H Foung; Jens Bukh
Journal:  Hepatology       Date:  2014-10-02       Impact factor: 17.425

Review 6.  Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.

Authors:  P Mark Hogarth; Geoffrey A Pietersz
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

7.  Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.

Authors:  Bruce D Wines; Hillary A Vanderven; Sandra E Esparon; Anne B Kristensen; Stephen J Kent; P Mark Hogarth
Journal:  J Immunol       Date:  2016-07-06       Impact factor: 5.422

8.  Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.

Authors:  Jonathan Richard; Beatriz Pacheco; Neelakshi Gohain; Maxime Veillette; Shilei Ding; Nirmin Alsahafi; William D Tolbert; Jérémie Prévost; Jean-Philippe Chapleau; Mathieu Coutu; Manxue Jia; Nathalie Brassard; Jongwoo Park; Joel R Courter; Bruno Melillo; Loïc Martin; Cécile Tremblay; Beatrice H Hahn; Daniel E Kaufmann; Xueling Wu; Amos B Smith; Joseph Sodroski; Marzena Pazgier; Andrés Finzi
Journal:  EBioMedicine       Date:  2016-09-09       Impact factor: 8.143

9.  HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations.

Authors:  Xiaochu Ma; Maolin Lu; Jason Gorman; Daniel S Terry; Xinyu Hong; Zhou Zhou; Hong Zhao; Roger B Altman; James Arthos; Scott C Blanchard; Peter D Kwong; James B Munro; Walther Mothes
Journal:  Elife       Date:  2018-03-21       Impact factor: 8.140

10.  Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses.

Authors:  Jonathan Richard; Jérémie Prévost; Amy E Baxter; Benjamin von Bredow; Shilei Ding; Halima Medjahed; Gloria G Delgado; Nathalie Brassard; Christina M Stürzel; Frank Kirchhoff; Beatrice H Hahn; Matthew S Parsons; Daniel E Kaufmann; David T Evans; Andrés Finzi
Journal:  mBio       Date:  2018-03-20       Impact factor: 7.867

View more
  30 in total

1.  Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5.

Authors:  Isabelle Staropoli; Jérémy Dufloo; Olivier Schwartz; Nicoletta Casartelli; Anaïs Ducher; Pierre-Henri Commere; Anna Sartori-Rupp; Sophie Novault; Timothée Bruel; Valérie Lorin; Hugo Mouquet
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

2.  CD4 Incorporation into HIV-1 Viral Particles Exposes Envelope Epitopes Recognized by CD4-Induced Antibodies.

Authors:  Shilei Ding; Romain Gasser; Gabrielle Gendron-Lepage; Halima Medjahed; William D Tolbert; Joseph Sodroski; Marzena Pazgier; Andrés Finzi
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 3.  The antibody response in HIV-1-infected donors.

Authors:  Simone I Richardson; Penny L Moore
Journal:  Curr Opin HIV AIDS       Date:  2019-07       Impact factor: 4.283

4.  Stabilizing the HIV-1 envelope glycoprotein State 2A conformation.

Authors:  Dani Vézina; Shang Yu Gong; William D Tolbert; Shilei Ding; Dung Nguyen; Jonathan Richard; Gabrielle Gendron-Lepage; Bruno Melillo; Amos B Smith; Marzena Pazgier; Andrés Finzi
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

5.  Recent insights into Fc-mediated effector responses to HIV-1.

Authors:  Margaret C Carpenter; Margaret E Ackerman
Journal:  Curr Opin HIV AIDS       Date:  2020-09       Impact factor: 4.283

6.  Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors.

Authors:  Annemarie Laumaea; Amos B Smith; Joseph Sodroski; Andrés Finzi
Journal:  Curr Opin HIV AIDS       Date:  2020-09       Impact factor: 4.283

7.  Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Authors:  Melissa C Grenier; Shilei Ding; Dani Vézina; Jean-Philippe Chapleau; William D Tolbert; Rebekah Sherburn; Arne Schön; Sambasivarao Somisetti; Cameron F Abrams; Marzena Pazgier; Andrés Finzi; Amos B Smith
Journal:  ACS Med Chem Lett       Date:  2019-11-15       Impact factor: 4.345

Review 8.  The Conformational States of the HIV-1 Envelope Glycoproteins.

Authors:  Qian Wang; Andrés Finzi; Joseph Sodroski
Journal:  Trends Microbiol       Date:  2020-05-14       Impact factor: 17.079

Review 9.  Antibodies for Human Immunodeficiency Virus-1 Cure Strategies.

Authors:  Evan Rossignol; Galit Alter; Boris Julg
Journal:  J Infect Dis       Date:  2021-02-15       Impact factor: 5.226

10.  Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells.

Authors:  Sai Priya Anand; Shilei Ding; William D Tolbert; Jérémie Prévost; Jonathan Richard; Hwi Min Gil; Gabrielle Gendron-Lepage; Wing-Fai Cheung; Haifeng Wang; Rebecca Pastora; Hirak Saxena; Warren Wakarchuk; Halima Medjahed; Bruce D Wines; Mark Hogarth; George M Shaw; Malcom A Martin; Dennis R Burton; Lars Hangartner; David T Evans; Marzena Pazgier; Doug Cossar; Michael D McLean; Andrés Finzi
Journal:  J Virol       Date:  2021-08-25       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.